Search Results - "Blackwood, L."

Refine Results
  1. 1

    Treatment of nasal tumours in dogs: a review by Mortier, J. R., Blackwood, L.

    Published in Journal of small animal practice (01-07-2020)
    “…Nasal tumours are common neoplasms in dogs and often represent a diagnostic and therapeutic challenge due to their confined location within the nasal cavities…”
    Get full text
    Journal Article
  2. 2

    238 A qualitative exploration of restraint decisions made by paramedics and advanced paramedics in the context of acute behavioural disturbance (ABD) in the pre-hospital setting by Lindridge, J, Blackwood, L, Edwards, T

    Published in BMJ open (01-05-2022)
    “…BackgroundAcute behavioural disturbance, also known as excited delirium, is a medical emergency. Paramedics are required to balance competing concerns,…”
    Get full text
    Journal Article
  3. 3

    Seniors don't use Medicare.Gov: how do eligible beneficiaries obtain information about Medicare Advantage Plans in the United States? by Rivera-Hernandez, Maricruz, Blackwood, Kristy L, Mercedes, Marquisele, Moody, Kyle A

    Published in BMC health services research (15-02-2021)
    “…Managed care programs in the US are becoming a preferred alternative among low-income individuals in the US. Every year during open enrollment, seniors can…”
    Get full text
    Journal Article
  4. 4

    A descriptive review of cardiac tumours in dogs and cats by Treggiari, E., Pedro, B., Dukes‐McEwan, J., Gelzer, A. R., Blackwood, L.

    Published in Veterinary & comparative oncology (01-06-2017)
    “…Cardiac tumours are uncommon in the canine and feline population and often an incidental finding. Common types include haemangiosarcoma (HSA), aortic body…”
    Get full text
    Journal Article
  5. 5

    Genome-wide analysis of canine oral malignant melanoma metastasis-associated gene expression by Bowlt Blacklock, K. L., Birand, Z., Selmic, L. E., Nelissen, P., Murphy, S., Blackwood, L., Bass, J., McKay, J., Fox, R., Beaver, S., Starkey, M.

    Published in Scientific reports (24-04-2019)
    “…Oral malignant melanoma (OMM) is the most common canine melanocytic neoplasm. Overlap between the somatic mutation profiles of canine OMM and human mucosal…”
    Get full text
    Journal Article
  6. 6

    Use of Oncept melanoma vaccine in 69 canine oral malignant melanomas in the UK by Verganti, S., Berlato, D., Blackwood, L., Amores‐Fuster, I., Polton, G. A., Elders, R., Doyle, R., Taylor, A., Murphy, S.

    Published in Journal of small animal practice (01-01-2017)
    “…Objectives Oral malignant melanomas carry a poor‐to‐guarded prognosis because of their local invasiveness and high metastatic propensity. The Oncept melanoma…”
    Get full text
    Journal Article
  7. 7

    Toxicity of metronomic cyclophosphamide chemotherapy in a UK population of cancer‐bearing dogs: a retrospective study by Harper, A., Blackwood, L.

    Published in Journal of small animal practice (01-04-2017)
    “…Objectives The objective of this study was to assess the incidence of toxicity in a group of cancer‐bearing dogs treated with metronomic chemotherapy…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy by Mason, S. L., Finotello, R., Blackwood, L.

    Published in Veterinary & comparative oncology (01-03-2018)
    “…The aims of this study were to report treatment outcomes for dogs with histiocytic sarcoma (HS) treated with both lomustine and epirubicin, and to report…”
    Get full text
    Journal Article
  10. 10

    European consensus document on mast cell tumours in dogs and cats by Blackwood, L, Murphy, S, Buracco, P, De Vos, J. P, De Fornel‐Thibaud, P, Hirschberger, J, Kessler, M, Pastor, J, Ponce, F, Savary-Bataille, K, Argyle, D. J

    Published in Veterinary & comparative oncology (01-09-2012)
    “…In preparing this document the Authors aimed to pool current information on canine and feline mast cell disease. The information was gathered from…”
    Get full text
    Journal Article
  11. 11

    Toxicity of cytarabine constant rate infusion in dogs with high‐grade non‐Hodgkin lymphoma with bone marrow or central nervous system involvement by Guillen, A, Finotello, R, Wynne, P, Harper, A, Killick, D, Amores‐Fuster, I, Blackwood, L

    Published in Australian veterinary journal (01-03-2020)
    “…Objective Cytarabine, a cell‐cycle phase‐specific antimetabolite, has been reported to improve outcomes in dogs with bone marrow (BM) or central nervous system…”
    Get full text
    Journal Article
  12. 12
  13. 13

    The diagnostic utility of lymph node cytology samples in dogs and cats by Amores-Fuster, I., Cripps, P., Graham, P., Marrington, A. M., Blackwood, L.

    Published in Journal of small animal practice (01-02-2015)
    “…OBJECTIVES The aim of this study was to determine common reasons for lymph node fine needle aspirates, cytological diagnoses reported and the frequency and…”
    Get full text
    Journal Article
  14. 14

    Canine oral mucosal mast cell tumours by Elliott, J. W., Cripps, P., Blackwood, L., Berlato, D., Murphy, S., Grant, I. A.

    Published in Veterinary & comparative oncology (01-03-2016)
    “…Mast cell tumours (MCTs) are the most common cutaneous tumours of dogs, however rarely they can arise from the oral mucosa. This subset of MCT is reported to…”
    Get full text
    Journal Article
  15. 15

    Post‐radiotherapy hypothyroidism in dogs treated for thyroid carcinomas by Amores‐Fuster, I., Cripps, P., Blackwood, L.

    Published in Veterinary & comparative oncology (01-03-2017)
    “…Hypothyroidism is a common adverse event after head and neck radiotherapy in human medicine, but uncommonly reported in canine patients. Records of 21 dogs…”
    Get full text
    Journal Article
  16. 16

    Temozolomide alone or in combination with doxorubicin as a rescue agent in 37 cases of canine multicentric lymphoma by Treggiari, E., Elliott, J. W., Baines, S. J., Blackwood, L.

    Published in Veterinary & comparative oncology (01-06-2018)
    “…Temozolomide (TMZ) is an alkylating agent previously used in conjunction with doxorubicin (DOX) to treat dogs with relapsed lymphoma. However, there are very…”
    Get full text
    Journal Article
  17. 17

    A preliminary investigation of the effect of sample collection technique on the cell and RNA content of fine‐needle aspirates of five canine tumours by Bowlt Blacklock, K. L., Ireland, J., Stewart, J., Murphy, S., Blackwood, L., Starkey, M.

    Published in Journal of small animal practice (01-04-2018)
    “…Objectives To evaluate the effect of syringe size, needle size, number of needle passes and operator experience on cell yield from tumour fine‐needle…”
    Get full text
    Journal Article
  18. 18

    Clinical outcome, PDGFRβ and KIT expression in feline histiocytic disorders: a multicentre study by Treggiari, E., Ressel, L., Polton, G. A., Benoit, J., Desmas, I., Blackwood, L.

    Published in Veterinary & comparative oncology (01-03-2017)
    “…Information about histiocytic disease in cats is limited. The aim of this study was to document clinical findings and outcome in feline histiocytic disorders,…”
    Get full text
    Journal Article
  19. 19

    Haematologic toxicity in dogs with mast cell tumours treated with vinblastine/prednisolone chemotherapy with/without radiotherapy by Stiborova, K., Treggiari, E., Amores‐Fuster, I., del Busto, I., Killick, D., Maddox, T., Marrington, M., Mason, S. L., Blackwood, L.

    Published in Journal of small animal practice (01-09-2019)
    “…Objectives To determine whether dogs with surgically excised mast cell tumours receiving a vinblastine/prednisolone chemotherapy protocol in combination with…”
    Get full text
    Journal Article
  20. 20

    Acute radiotherapy toxicity in 57 dogs with gross and microscopic mast cell tumours by Blackwood, L., Tanis, J. B., Harper, A., Amores‐Fuster, I., Killick, D. R., Finotello, R.

    Published in Veterinary & comparative oncology (01-12-2018)
    “…Mast cell tumours (MCTs) are commonly treated with radiation therapy, most often in a microscopic disease setting. Poorer outcomes are expected in patients…”
    Get full text
    Journal Article